Absence of procarboxypeptidase R induces complement-mediated lethal inflammation in lipopolysaccharide-primed mice

Journal of Immunology

Volumn 173, Issue 7, 2004, Pages 4669-4674

  Asai, Suzuka ^a   Sato, Tomoo ^a,c   Tada, Toyohiro ^b   Miyamoto, Tomomi ^b   Kimbara, Noriaki ^a   Motoyama, Notoora ^d   Okada, Hidechika ^a,c   Okada, Noriko ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b NAGOYA CITY UNIVERSITY   (Japan)

^c Fukushimura Hospital   (Japan)

^d NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ARGININE; ARGININE CARBOXYPEPTIDASE; BRADYKININ; CARBOXYPEPTIDASE; CARBOXYPEPTIDASE R; COBROTOXIN; COMPLEMENT; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; ENKEPHALIN; LIPOPOLYSACCHARIDE; LYSINE; PLASMIN; PROCARBOXYPEPTIDASE R; THROMBIN; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR; TRYPSIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; EXON; FEMALE; GENE EXPRESSION; IN VIVO STUDY; INFLAMMATION; KNOCKOUT MOUSE; LETHALITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROVOCATION TEST; SENSITIZATION;

EID: 4644336103     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.7.4669     Document Type: Article

References (34)

1. Campbell, W. N., X. Ding, and S. E. Goldblum. 1992. Interleukin-1α and -β augment pulmonary artery transendothelial albumin flux in vitro. Am. J. Physiol. 263:L128.
2. Bone, R. C. 1992. Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). J. Am. Med. Assoc. 268:3452.
3. Jones, D. K. 1990. Markers for impending adult respiratory distress syndrome. Respir. Med. 84:89.
4. Stove, S., T. Welte, T. O. Wagner, A. Kola, A. Klos, W. Bautsch, and J. Kohl. 1996. Circulating complement proteins in patients with sepsis or systemic inflammatory response syndrome. Clin. Diagn. Lab. Immunol. 3:175.
5. Goya, T., T. Morisaki, and M. Torisu. 1994. Immunologic assessment of host defense impairment in patients with septic multiple organ failure: relationship between complement activation and changes in neutrophil function. Surgery 115:145.
6. Campbell, W., and H. Okada. 1989. An arginine specific carboxypeptidase generated in blood during coagulation or inflammation which is unrelated to carboxypeptidase N or its subunits. Biochem. Biophys. Res. Commun. 162:933.
7. Redlitz, A., A. K. Tan, D. L. Eaton, and E. F. Plow. 1995. Plasma carboxypeptidases as regulators of the plasminogen system. J. Clin. Invest. 96:2534.
8. Shinohara, T., C. Sakurada, T. Suzuki, O. Takeuchi, W. Campbell, S. Ikeda, N. Okada, and H. Okada. 1994. Pro-carboxypeptidase R cleaves bradykinin following activation. Int. Arch. Allergy Immunol. 103:400.
9. Bokisch, V. A., H. J. Muller-Eberhard, and C. G. Cochrane. 1969. Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum. J. Exp. Med. 129:1109.
10. Eaton, D. L., B. E. Malloy, S. P. Tsai, W. Henzel, and D. Drayna. 1991. Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma. J. Biol. Chem. 266:21833.
11. Bajzar, L., J. Morser, and M. Nesheim. 1996. TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J. Biol. Chem. 271:16603.
12. Kato, T., H. Akatsu, T. Sato, S. Matsuo, T. Yamamoto, W. Campbell, N. Hotta, N. Okada, and H. Okada. 2000. Molecular cloning and partial characterization of rat procarboxypeptidase R and carboxypeptidase N. Microbiol. Immunol. 44:719.
13. Sato, T., T. Miwa, H. Akatsu, N. Matsukawa, K. Obata, N. Okada, W. Campbell, and H. Okada. 2000. Pro-carboxypeptidase R is an acute phase protein in the mouse, whereas carboxypeptidase N is not. J. Immunol. 165:1053.
14. Campbell, W. D., E. Lazoura, N. Okada, and H. Okada. 2002. Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N. Microbiol. Immunol. 46:131.
15. Kawamura, T., N. Okada, and H. Okada. 2002. Elastase from activated human neutrophils activates procarboxypeptidase R. Microbiol. Immunol. 46:225.
16. Komura, H., K. Obata, W. Campbell, M. Yumoto, Y. Shimomura, H. Katsuya, N. Okada, and H. Okada. 2002. Effect of anticoagulants in colorimetric assay for basic carboxypeptidases. Microbiol. Immunol. 46:115.
17. Schatteman, K. A., F. J. Goossens, S. S. Scharpe, H. M. Neels, and D. F. Hendriks. 1999. Assay of procarboxypeptidase U, a novel determinant of the fibrinolytic cascade, in human plasma. Clin. Chem. 45:807.
18. Laudes, I. J., J. C. Chu, M. Huber-Lang, R. F. Guo, N. C. Riedemann, J. V. Sarma, F. Mahdi, H. S. Murphy, C. Speyer, K. T. Lu, et al. 2002. Expression and function of C5a receptor in mouse microvascular endothelial cells. J. Immunol. 169:5962.
19. Komura, H., Y. Shimomura, M. Yumoto, H. Katsuya, N. Okada, and H. Okada. 2002. Heat stability of carboxypeptidase R of experimental animals. Microbiol. Immunol. 46:217.
20. Lachmann, P. J., L. Halbwachs, A. Gewurz, and H. Gewurs. 1976. Purification of cobra venom factor from phospholipase A contaminant. Immunology 31:961.
21. Riedemann, N. C., R. F. Guo, V. J. Sarma, I. J. Laudes, M. Huber-Lang, R. L. Warner, E. A. Albrecht, C. L. Speyer, and P. A. Ward. 2002. Expression and function of the C5a receptor in rat alveolar epithelial cells. J. Immunol. 168:1919.
22. Mizuno, M., K. Nishikawa, N. Okada, S. Matsuo, K. Ito, and H. Okada. 1999. Inhibition of a membrane complement regulatory protein by a monoclonal antibody induces acute lethal shock in rats primed with lipopolysaccharide. J. Immunol. 162:5477.
23. Oshima, G., J. Kato, and E. G. Erdos. 1975. Plasma carboxypeptidase N, subunits and characteristics. Arch. Biochem. Biophys. 170:132.
24. Gebhard, W., M. Schube, and M. Eulitz. 1989. cDNA cloning and complete primary structure of the small, active subunit of human carboxypeptidase N (kininase 1). Eur. J. Biochem. 178:603.
25. Nagashima, M., Z. F. Yin, L. Zhao, K. White, Y. Zhu, N. Lasky, M. Halks-Miller, G. J. Broze, Jr., W. P. Fay, and J. Morser. 2002. Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life. J. Clin. Invest. 109:101.
26. Ahmadizadeh, M., R. Echt, C. H. Kuo, and J. B. Hook. 1984. Sex and strain differences in mouse kidney: Bowman's capsule morphology and susceptibility to chloroform. Toxicol. Lett. 20:161.
27. Haensly, W. E., and J. C. Lee. 1986. Metaplasia of the parietal layer of Bowman's capsule: a histopathological survey of the human kidney. Histol. Histopathol. 1:363.
28. Hanker, J. S., J. W. Preece, and E. K. MacRae. 1975. Cytochemical correlate of structural sexual dimorphism in glandular tissue of the mouse. I. Studies of the renal glomerular capsule. Histochemtstry 44:225.
29. Eshenbrenner, A. B., and E. Miller. 1945. Sex difference in kidney morphology and chloroform necrosis. Science 102:302.
30. Matsuo, S., S. Ichida, H. Takizawa, N. Okada, L. Baranyi, A. Iguchi, B. P. Morgan, and H. Okada. 1994. In vivo effects of monoclonal antibodies that functionally inhibit complement regulatory proteins in rats. J. Exp. Med. 180:1619.
31. Haviland, D. L., R. L. McCoy, W. T. Whitehead, H. Akama, E. P. Molmenti, A. Brown, J. C. Haviland, W. C. Parks, D. H. Perlmutter, and R. A. Wetsel. 1995. Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung. J. Immunol. 154:1861.
32. Akatsu, H., T. Miwa, C. Sakurada, Y. Fukuoka, J. A. Ember, T. Yamamoto, T. E. Hugli, and H. Okada. 1997. cDNA cloning and characterization of rat C5a anaphylatoxin receptor. Microbiol. Immunol 41:575.
33. Fukuoka, Y., J. A. Ember, and T. E. Hugli. 1998. Cloning and characterization of rat C3a receptor: differential expression of rat C3a and C5a receptors by LPS stimulation. Biochem. Biophys. Res. Commun. 242:663.
34. Nishikawa, K., S. Matsuo, N. Okada, B. P. Morgan, and H. Okada. 1996. Local inflammation caused by a monoclonal antibody that blocks the function of the rat membrane inhibitor of C3 convertase. J. Immunol 156:1182.